Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Medtech (Hangzhou) Inc. has scheduled the Second Class Meeting of H Shareholders for December 5, 2024, where key amendments to company rules and Articles of Association will be discussed. Shareholders are encouraged to participate and vote on these significant resolutions, which could impact the company’s governance structure.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.